Other OTC • Healthcare • Drug Manufacturers - General • JP • USD
Astellas Pharma Inc. (ALPMY) has a consensus analyst rating of Buy, based on 3 analysts covering the stock. Of those, 2 recommend buying, 1 recommend holding, and 0 recommend selling.
No price target data available.
Be the first to know when stocks drop below their intrinsic value.
